Delivery Order SPE2DB24D2003-SPE2DB25FXHR1
Award Date
5/13/25
Potential Completion Date
5/14/25
Potential Value
$8.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Ondansetron ODT 8 mg tablets. The contract is a Delivery Order with a Firm Fixed Price of $2,402.37 and a performance period through March 19, 2025. The contract was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,493.29 delivery order contract is for the supply of 4,567,977,353 units of the medication Ondansetron ODT 8 mg tablet. The contract is a firm fixed-price, non-set-aside award with a performance period through April 2025. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide ondansetron ODT 4 mg tablets. The contract is a delivery order valued at $20,665.09 with a firm fixed price and an ultimate completion date of November 14, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for providing...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Ondansetron ODT 8 mg tablets. The $11,254.23 fixed-price Delivery Order contract has a completion date of May 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ondansetron ODT 8 mg tablets. The contract is a firm fixed-price delivery order with a ceiling value of $12,342.69 and a performance period ending on May 5, 2025. This award is not set-aside and represents open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ondansetron ODT 4 mg tablets. The contract has a firm fixed price and is a delivery order with a total ceiling value of $24,826.91. The performance period extends through May 7, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This federal contract award, valued at $4,127.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ondansetron ODT 4 mg tablets. The contract is a firm-fixed-price delivery order that does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg tablets in quantities of 30. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $8,664.63 and a period of performance ending on May 30, 2025. The contract is not set-aside and is an open competition award. AmerisourceBergen Drug Corp also...
This federal contract award, valued at $48,550.59, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of 4,568,143,838 units of the medication Ondansetron ODT 8 mg Tablet, with a performance period ending on May 6, 2025. The contract is a firm fixed-price arrangement and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Ondansetron ODT 4 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $15,250.86 and a performance period through January 30, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...